The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene
- 11 September 2008
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 217 (1), 83-93
- https://doi.org/10.1002/path.2445
Abstract
The NR4A3 nuclear receptor is implicated in the development of extraskeletal myxoid chondrosarcoma (EMC), primitive sarcoma unrelated to conventional chondrosarcomas, through a specific fusion with EWSR1 resulting in an aberrant fusion protein that is thought to disrupt the transcriptional regulation of specific target genes. We performed an expression microarray analysis of EMC tumours expressing the EWSR1/NR4A3 fusion protein, comparing their expression profiles to those of other sarcoma types. We thereby identified a set of genes significantly overexpressed in EMC relative to other sarcomas, including PPARG and NDRG2. Western blot or immunohistochemical analyses confirm that PPARG and NDRG2 are expressed in tumours positive for EWSR1/NR4A3. Bioinformatic analysis identified a DNA response element for EWSR1/NR4A3 in the PPARG promoter, and band‐shift experiments and transient transfections indicate that EWSR1/NR4A3 can activate transcription through this element. Western blots further show that an isoform of the native NR4A3 receptor lacking the C‐terminal domain is very highly expressed in tumours positive for EWSR1/NR4A3, and co‐transfections of this isoform along with EWSR1/NR4A3 indicate that it may negatively regulate the activity of the fusion protein on the PPARG promoter. These results suggest that the overall expression of PPARG in EMC may be regulated in part by the balance between EWSR1/NR4A3 and NR4A3, and that PPARG may play a crucial role in the development of these tumours. The specific up‐regulation of PPARG by EWSR1/NR4A3 may also have potential therapeutic implications. Copyright © 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 60 references indexed in Scilit:
- NR4A Orphan Nuclear Receptors Modulate Insulin Action and the Glucose Transport SystemPublished by Elsevier BV ,2007
- Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell linesBiochemical and Biophysical Research Communications, 2007
- PPARγ in human and mouse physiologyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cellsBritish Journal of Cancer, 2006
- A novel N‐terminal hydrophobic motif mediates constitutive degradation of serum‐ and glucocorticoid‐induced kinase‐1 by the ubiquitin–proteasome pathwayThe FEBS Journal, 2006
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003
- Neuron-Derived Orphan Receptor-1 (NOR-1) Modulates Vascular Smooth Muscle Cell ProliferationCirculation Research, 2003
- Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcomaOncogene, 1999
- The isolation and characterization of MINOR, a novel mitogen-inducible nuclear orphan receptorMolecular Endocrinology, 1995
- Molecular Cloning of a Novel Thyroid/Steroid Receptor Superfamily Gene from Cultured Rat Neuronal CellsBiochemical and Biophysical Research Communications, 1994